How often should Tdap (Tetanus, diphtheria, and pertussis) be updated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tdap Booster Frequency

Tdap (or Td) should be administered every 10 years as a routine booster dose throughout adult life. 1, 2, 3

Standard Booster Schedule

The Advisory Committee on Immunization Practices (ACIP) recommends decennial (every 10 years) booster doses of either Td or Tdap for all adults who have completed their primary vaccination series. 4, 1, 3 This 10-year interval applies throughout life, including for elderly individuals aged ≥65 years. 2, 3

Since 2019, ACIP guidelines provide flexibility in vaccine selection, allowing either Td or Tdap to be used for routine 10-year boosters. 4, 1 Previously, only Td was recommended for subsequent doses after the initial Tdap, but current recommendations permit either vaccine. 4, 3

Key Timing Considerations

First Tdap Dose

  • Adults who have never received Tdap should receive one dose as soon as feasible, regardless of the interval since their last tetanus-containing vaccine. 1, 2, 3
  • Tdap should be administered regardless of when the last Td was given—do not delay. 1, 3

Subsequent Boosters

  • After receiving Tdap, continue with either Td or Tdap boosters every 10 years. 2, 3
  • The vaccination series does not need to be restarted if doses are delayed—simply continue from where the patient left off. 2, 3

Important Exceptions to the 10-Year Rule

Wound Management (5-Year Rule)

For contaminated or tetanus-prone wounds, a booster is indicated if more than 5 years have elapsed since the last tetanus-containing vaccine. 1, 2, 3 This shorter interval applies specifically to wound management, not routine prophylaxis. 1, 3

  • Tdap is preferred over Td for wound management in patients who have not previously received Tdap or whose Tdap history is unknown. 2, 3
  • Clean, minor wounds only require a booster if the last dose was more than 10 years ago. 1

Pregnancy

Pregnant women should receive one dose of Tdap during each pregnancy, between 27-36 weeks gestation, regardless of prior vaccination history or interval since last tetanus vaccine. 1, 2, 5 This recommendation applies even if the woman received Tdap less than 10 years ago. 5

Critical Pitfalls to Avoid

Do not give tetanus boosters more frequently than every 10 years for routine immunization. 1, 3 Administering boosters too frequently can cause Arthus-type hypersensitivity reactions—severe local reactions characterized by pain, swelling, and induration developing 4-12 hours post-injection. 1, 6

  • Persons who experienced an Arthus reaction following a previous tetanus toxoid-containing vaccine should not receive another dose until at least 10 years have elapsed. 1, 6
  • The only exceptions to the 10-year minimum interval are wound management (5-year rule) and pregnancy (any interval). 1, 2, 3

Evidence Supporting the 10-Year Interval

Complete primary tetanus vaccination provides long-lasting protection of ≥10 years for most recipients, which forms the scientific basis for the decennial booster recommendation. 1 Clinical trials demonstrate that repeat doses of Tdap at 10-year intervals are safe and highly immunogenic. 4, 7, 8

A study of young adults receiving a second Tdap booster 10 years after their first showed the vaccine was highly immunogenic and well tolerated, with antibody responses similar in magnitude to the initial booster. 7 This supports the use of Tdap as a decennial booster. 7, 8

References

Guideline

Tetanus Vaccination Schedule and Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tetanus Vaccination Schedule

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tetanus Vaccine Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.